CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes SVP, Finance and CAO gave up 649 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Director sold 24,042 shares at $350.00 ($8,414,700)
- 4 Planned sale CEVP, Disc & Safety Assessment sold 2,156 shares at $344.41 ($742,548)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale CEVP, Disc & Safety Assessment sold 981 shares at $308.44 ($302,580)
- 144 Insider Sale of Securities
- 4 Open-market buy EVP & Chief Financial Officer bought 10 shares at $297.43 ($2,974)
- 8-K Event Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Director sold 33,561 shares at $300.00 ($10,068,300)
- 144 Insider Sale of Securities
- 4 Gift Chief Executive Officer gave 528 shares (gift)
- 4 Planned sale CEVP, Disc & Safety Assessment sold 2,039 shares at $294.12 ($599,711)
- 4 Open-market sale Director sold 573 shares at $285.24 ($163,443)
Page 1 of 123 · 2,446 filings